Immunisation against heterologous type II collagen induces arthritis in mice.

PubWeight™: 7.08‹?› | Rank: Top 1%

🔗 View Article (PMID 6153460)

Published in Nature on February 14, 1980

Authors

J S Courtenay, M J Dallman, A D Dayan, A Martin, B Mosedale

Articles citing this

(truncated to the top 100)

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med (2003) 14.60

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76

Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med (1998) 3.53

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest (2006) 3.51

Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med (1985) 2.92

The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol (2009) 2.87

Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27

B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol (1998) 2.27

Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest (1989) 2.20

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut (2004) 2.15

Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol (1998) 2.03

Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med (1985) 2.01

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A (2000) 1.96

Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med (1999) 1.92

Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. Immunology (1981) 1.92

An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89

Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci U S A (1995) 1.85

Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med (2000) 1.75

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest (2000) 1.74

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A (1995) 1.71

IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther (2013) 1.66

HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66

Interleukin-35: odd one out or part of the family? Immunol Rev (2008) 1.60

Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther (2006) 1.58

Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol (1983) 1.58

Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52

Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. J Biol Chem (2010) 1.51

The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology (2001) 1.49

Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology (1988) 1.41

Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38

T cells in rheumatoid arthritis. Arthritis Res Ther (2008) 1.33

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther (2006) 1.32

Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res (2002) 1.31

Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.26

Genes on the X chromosome affect development of collagen-induced arthritis in mice. Clin Exp Immunol (1993) 1.26

Amelioration of collagen-induced arthritis by thrombin inhibition. J Clin Invest (2001) 1.24

Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis. Pain (2010) 1.20

Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol (2010) 1.16

Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther (2007) 1.16

Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol (1991) 1.15

Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol (2004) 1.15

Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen. Clin Exp Immunol (1985) 1.15

Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann Rheum Dis (1987) 1.14

The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. J Clin Immunol (2005) 1.13

Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12

Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice. Proc Natl Acad Sci U S A (1989) 1.10

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis (2004) 1.09

CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol (1994) 1.09

Effect of pregnancy on collagen-induced arthritis in mice. Clin Exp Immunol (1987) 1.08

The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin Exp Immunol (1990) 1.06

Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med (1985) 1.05

Rodent models of arthritis: relevance for human disease. Clin Exp Immunol (1998) 1.04

1 Alpha 2 alpha 3 alpha collagen is arthritogenic. Ann Rheum Dis (1983) 1.04

Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol (1986) 1.02

Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J Immunol (2008) 1.01

Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis. J Exp Med (1992) 1.00

Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J Clin Immunol (2004) 1.00

Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin Exp Immunol (1999) 1.00

Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats. Clin Exp Immunol (1982) 1.00

Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell. J Clin Invest (1985) 1.00

What do anti-collagen antibodies mean? Ann Rheum Dis (1990) 0.99

Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest (1994) 0.99

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol Biochem Behav (2011) 0.98

Measuring persistent temporomandibular joint nociception in rats and two mice strains. Physiol Behav (2010) 0.98

Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant. Immunology (1995) 0.98

Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann Rheum Dis (1983) 0.97

Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Immunology (2000) 0.97

Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in rats. Clin Exp Immunol (1988) 0.97

Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1997) 0.96

Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis. Arthritis Res Ther (2011) 0.96

An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. PLoS One (2012) 0.96

Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskelet Disord (2010) 0.95

Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. Br J Pharmacol (2005) 0.95

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha. Ann Rheum Dis (2000) 0.93

Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil. Mediators Inflamm (2006) 0.93

A study on type II collagen-induced arthritis in allogeneic bone marrow chimaeras. Immunology (1989) 0.92

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. J Clin Invest (2014) 0.91

The complex role of Fcgamma receptors in the pathology of arthritis. Springer Semin Immunopathol (2006) 0.91

Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis. Ann Rheum Dis (1982) 0.91

IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis. Arthritis Res Ther (2011) 0.91

Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm Res (2010) 0.91

Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology (2006) 0.91

A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest (1999) 0.91

Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci U S A (1999) 0.90

Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategies. Arthritis Res Ther (2004) 0.90

Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J Clin Immunol (2004) 0.90

Effects of pravastatin in murine collagen-induced arthritis. Rheumatol Int (2006) 0.90

Effects of cyclosporin on collagen induced arthritis in mice. Ann Rheum Dis (1986) 0.90

B Cell in Autoimmune Diseases. Scientifica (Cairo) (2012) 0.90

Effects of exposure to hyperbaric oxygen on oxidative stress in rats with type II collagen-induced arthritis. Clin Exp Med (2009) 0.89

Quantitative dynamic models of arthritis progression in the rat. Pharm Res (2008) 0.89

Identification and characterization of a major tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice. Immunology (1995) 0.88

An arthritogenic lymphokine in the rat. J Exp Med (1985) 0.88

Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies. Immunology (1991) 0.88

Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflamm (1992) 0.88

The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther (2009) 0.88

Indian herbal medicines: possible potent therapeutic agents for rheumatoid arthritis. J Clin Biochem Nutr (2007) 0.88

Articles by these authors

(truncated to the top 100)

Uncertainty in predictions of the climate response to rising levels of greenhouse gases. Nature (2005) 7.46

Representation of manipulable man-made objects in the dorsal stream. Neuroimage (2000) 4.05

The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res (1999) 3.83

Attribute-based neural substrates in temporal cortex for perceiving and knowing about objects. Nat Neurosci (1999) 3.83

Distributed representation of objects in the human ventral visual pathway. Proc Natl Acad Sci U S A (1999) 3.76

Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev (1983) 3.70

Properties and mechanisms of perceptual priming. Curr Opin Neurobiol (1998) 3.69

Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging (2001) 3.48

What do gastroenterologists in Europe tell cancer patients? Lancet (1993) 3.42

Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol (2005) 3.34

The effect of face inversion on activity in human neural systems for face and object perception. Neuron (1999) 3.13

Health spending in 1998: signals of change. The Health Accounts Team. Health Aff (Millwood) (2000) 2.92

Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry (1976) 2.89

Ontogeny of orientation flight in the honeybee revealed by harmonic radar. Nature (2000) 2.86

A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron (1999) 2.82

How easy is it to contact the duty medical doctor responsible for acute admissions? BMJ (1990) 2.80

Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med (1998) 2.65

Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60

MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. Eur J Immunol (1984) 2.56

Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance. J Biol Chem (1975) 2.51

The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells. Eur J Immunol (1982) 2.48

Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci (1999) 2.41

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clin Infect Dis (2006) 2.40

Modulation of emotion by cognition and cognition by emotion. Neuroimage (2007) 2.36

Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS) Am J Clin Pathol (1998) 2.35

Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in "normal" patients. Acta Neuropathol (1970) 2.30

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol (2001) 2.24

Systemic cytokine response after major surgery. Br J Surg (1992) 2.23

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. Lancet (2013) 2.23

Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med (1991) 2.21

Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Pediatr Pulmonol (2001) 2.20

Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J (1991) 2.18

Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol (2003) 2.15

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol (1991) 2.08

Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program. Ann Intern Med (1989) 2.07

Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol (2000) 2.03

The rhythm of the heart in active elderly subjects. Am Heart J (1980) 2.02

Neuromuscular fatigue differs following unilateral vs bilateral sustained submaximal contractions. Scand J Med Sci Sports (2011) 2.00

Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol Microbiol (1999) 1.88

Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85

Association of brain damage with therapeutic abortion induced by amniotic-fluid replacement: report of two cases. Br Med J (1966) 1.83

Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol (2004) 1.81

Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol Microbiol (1996) 1.79

Pathogenesis of syringomyelia. Lancet (1972) 1.79

Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry (2001) 1.79

Antioxidant capacity, vitamin C, phenolics, and anthocyanins after fresh storage of small fruits. J Agric Food Chem (1999) 1.73

Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J (1991) 1.72

Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br J Radiol (2002) 1.71

The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol Microbiol (2000) 1.70

Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem Sci (1998) 1.69

Polymerase chain reaction for detection of verocytotoxigenic Escherichia coli isolated from animal and food sources. Mol Cell Probes (1992) 1.67

Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications. Heart (2001) 1.66

Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer (2006) 1.66

Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest (1993) 1.65

Identification of Ss protein as murine C4. Nature (1975) 1.63

The prevalence of osteoporosis in nursing home residents. Osteoporos Int (1999) 1.59

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer (2006) 1.57

Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11. Br J Cancer (1989) 1.57

Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci (2000) 1.56

Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol (1991) 1.56

Quantitative histological studies on the aged human brain. II. Senile plaques and neurofibrillary tangles in senile dementia (with an appendix on their occurrence in cases of carcinoma). Acta Neuropathol (1970) 1.55

Investigation of anthropometric and work-rate profiles of elite South American international soccer players. J Sports Med Phys Fitness (2000) 1.55

Atypical teratomas of the pineal and hypothalamus. J Pathol Bacteriol (1966) 1.54

Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1. Can J Biochem (1976) 1.52

Changes in baroreceptor sensitivity for heart rate during normotensive pregnancy and the puerperium. Clin Sci (Lond) (2000) 1.50

The children of divorce parenting intervention: outcome evaluation of an empirically based program. Am J Community Psychol (1993) 1.49

Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci (2001) 1.49

Interscalene brachial plexus block with continuous intraarticular infusion of ropivacaine. Anesth Analg (2001) 1.49

Demyelinating peripheral neuropathy and liver disease. Lancet (1967) 1.48

Estimation of euglobulin lysis time using a time-saving recorder. Lab Pract (1969) 1.48

The representation of objects in the human occipital and temporal cortex. J Cogn Neurosci (2000) 1.47

Potential role for advanced trauma life support programme in improving trauma care in Jamaica. West Indian Med J (2003) 1.47

Word production and comprehension in Alzheimer's disease: the breakdown of semantic knowledge. Brain Lang (1983) 1.47

The role of observer error in antenatal dipstick proteinuria analysis. Br J Obstet Gynaecol (1999) 1.45

First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy). Ultrasound Obstet Gynecol (2002) 1.44

SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol (2007) 1.44

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44

Older subjects show no age-related decrease in cardiac baroreceptor sensitivity. Age Ageing (1999) 1.43

Studies of l(3)c43hs1 a polyphasic, temperature-sensitive mutant of Drosophila melanogaster with a variety of imaginal disc defects. Dev Biol (1977) 1.43

Two-dimensional viscous froth model for foam dynamics. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 1.42

Rapid diagnosis of encephalitis by immunofluorescent examination of cerebrospinal-fluid cells. Lancet (1973) 1.41

Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplant (1999) 1.41

Qualitative analysis: a guide to best practice--forensic science extension. Sci Justice (2000) 1.40

Comparison of ribotyping, pulsed-field gel electrophoresis and random amplified polymorphic DNA for typing Clostridium difficile strains. FEMS Microbiol Lett (1994) 1.40

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Evaluation of the BTS approach to the testing of substances and preparations for their acute toxicity. Hum Toxicol (1987) 1.40

Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci (1998) 1.40

Neuropathological effects of persistent infection of mice by mouse hepatitis virus. Infect Immun (1975) 1.39

A clinical scientist's view of preclinical drug testing requirements. Hum Exp Toxicol (1991) 1.39

Work of breathing, inspiratory flow response, and expiratory resistance during continuous positive airway pressure with the ventilators EVITA-2, EVITA-4 and SV 300. Intensive Care Med (1998) 1.39

Partial solubility parameters and solvatochromic parameters for predicting the solubility of single and multiple drugs in individual solvents. J Pharm Sci (1993) 1.39

Prediction of the behaviour of a single flow-injection manifold. Talanta (1985) 1.39

Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int J Tuberc Lung Dis (2010) 1.38

Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J Clin Exp Neuropsychol (1990) 1.38

Uterine artery Doppler at 11-14 weeks of gestation in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol (2001) 1.38

Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J Biol Chem (1991) 1.38

The pyruvate dehydrogenase multi-enzyme complex from Gram-negative bacteria. Biochim Biophys Acta (1998) 1.38

Complementary neural mechanisms for tracking items in human working memory. Science (2000) 1.37

13C-NMR relaxation in three DNA oligonucleotide duplexes: model-free analysis of internal and overall motion. Biochemistry (1994) 1.37

A multiplex PCR for unequivocal differentiation of all encapsulated and non-encapsulated genotypes of Trichinella. Int J Parasitol (1999) 1.37